Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II for Distributive Shock in Heart Transplant or LVAD Patients
NCT04904562Phase 4Terminated
- Sponsor
- Northwestern University
- Start
- Jun 2022
- Primary completion
- May 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in Distributive shock (DS), sponsored by Northwestern University. Started Jun 2022; status: terminated.
02
Drugs
Angiotensin II
03
Conditions
Distributive shock (DS)
Beyond the preview
Go deeper on NCT04904562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904562.